Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Prenetics Global Ltd PRE.P.I


Primary Symbol: PRE Alternate Symbol(s):  PREJF

Healthcare
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients.


NDAQ:PRE - Post by User

Prenetics Global Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by mairymducaon Jun 14, 2016 10:59am
211 Views
Post# 24963623

Ellos tienen poder y dinero pero nosotros tenemos 4 razones

Ellos tienen poder y dinero pero nosotros tenemos 4 razonesfundamentales para ganar.
1. No estamos dispuestos a perder lo poco que tenemos
2. Tenemos la razn
3. Tenemos la informacin y el poder de la informatica
4. Somos muchos 

Ahora pregunto quienes estan dispuestos a ayudar a reproducir la verdad 1 millon de veces?????????
estando clinton involucrado con Guistra no le conviene que se sepa que tiene sociedad con delincuentes asi que a ellos les conviene la demora y a nosotros no.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities